By Josh White
Date: Tuesday 24 Feb 2026
(Sharecast News) - OptiBiotix Health announced the start of a clinical study with Hull University Teaching Hospitals NHS Trust on Tuesday, to assess whether its 'WellBiome' prebiotic could improve cardiac surgery outcomes and deliver potential cost savings for the NHS.
| Holding(s) in Company | 02-Jan-2026 | ShareCast |
| Director dealings: Optibiotix Health finance dir... | 02-Oct-2025 | ShareCast |
| OptiBiotix inks distribution deal with weight ma... | 20-Aug-2025 | ShareCast |
| OptiBiotix announces launch of product with majo... | 14-Aug-2025 | ShareCast |
| OptiBiotix posts solid first-half revenue growth | 28-Jul-2025 | ShareCast |
| WellBiome® clinical trial on surgical outco... | 24-Feb-2026 | 07:00 | RNS |
| Statement: SkinBioTherapeutics Announcement | 17-Feb-2026 | 07:00 | RNS |
| Large Order and Record Early Orders for 2026 | 21-Jan-2026 | 07:00 | RNS |
| Holding(s) in Company | 02-Jan-2026 | 07:00 | RNS |
| Holding(s) in Company | 02-Jan-2026 | 07:00 | RNS |
| £5.7m float for weight-fighting OptiBiotix after... | 04-Aug-2014 | Express & Star |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 6.35p |
| Change Today | 0.100p |
| % Change | 1.60 % |
| 52 Week High | 20.50 |
| 52 Week Low | 5.85 |
| Volume | 570,251 |
| Shares Issued | 103.30m |
| Market Cap | £6.56m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:27 | 15,141 @ 6.48p |
| 12:22 | 15,351 @ 6.48p |
| 11:32 | 3,797 @ 6.48p |
| 08:50 | 300,000 @ 6.23p |
| 09:20 | 3,000 @ 6.28p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research